Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 19,998 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $0.78, for a total transaction of $15,598.44. Following the completion of the transaction, the chief executive officer now directly owns 919,799 […]

Related Keywords

Ohio , United States , Hong Kong , Howardw Robin , , First Citizens Bank Trust Co , Jefferies Financial Group , Nektar Therapeutics , Goldman Sachs Group Inc , Y Intercept Hong Kong Ltd , Nektar Therapeutics Company Profile , Get Free Report , Employees Retirement System , Citizens Bank , Intercept Hong Kong Ltd , Sachs Group , Nektar Therapeutics Daily , Nasdaq Nktr , Nktr , Medical , 64026810 , Insider Trading , Nsider Trades , Stocks ,